company background image
300401 logo

Zhejiang Garden BiopharmaceuticalLtd XSEC:300401 Stock Report

Last Price

CN¥14.87

Market Cap

CN¥8.1b

7D

-3.6%

1Y

28.1%

Updated

25 Dec, 2024

Data

Company Financials +

Zhejiang Garden Biopharmaceutical Co.,Ltd.

XSEC:300401 Stock Report

Market Cap: CN¥8.1b

My Notes

Capture your thoughts, links and company narrative

Zhejiang Garden Biopharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zhejiang Garden BiopharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥14.87
52 Week HighCN¥18.46
52 Week LowCN¥7.58
Beta0.085
1 Month Change2.41%
3 Month Change15.27%
1 Year Change28.08%
3 Year Change5.46%
5 Year Change19.44%
Change since IPO-21.74%

Recent News & Updates

Recent updates

Shareholder Returns

300401CN PharmaceuticalsCN Market
7D-3.6%-1.7%-1.0%
1Y28.1%-4.3%10.8%

Return vs Industry: 300401 exceeded the CN Pharmaceuticals industry which returned -3% over the past year.

Return vs Market: 300401 exceeded the CN Market which returned 12.3% over the past year.

Price Volatility

Is 300401's price volatile compared to industry and market?
300401 volatility
300401 Average Weekly Movement8.6%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300401 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300401's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000943Huanzheng Mawww.hybiotech.com

Zhejiang Garden Biopharmaceutical Co.,Ltd. manufactures and supplies lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, and refined lanolin products in China. It offers cholesterol; feed grade cholesterol; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3.

Zhejiang Garden Biopharmaceutical Co.,Ltd. Fundamentals Summary

How do Zhejiang Garden BiopharmaceuticalLtd's earnings and revenue compare to its market cap?
300401 fundamental statistics
Market capCN¥8.08b
Earnings (TTM)CN¥284.89m
Revenue (TTM)CN¥1.13b

28.4x

P/E Ratio

7.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300401 income statement (TTM)
RevenueCN¥1.13b
Cost of RevenueCN¥473.20m
Gross ProfitCN¥661.26m
Other ExpensesCN¥376.38m
EarningsCN¥284.89m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.52
Gross Margin58.29%
Net Profit Margin25.11%
Debt/Equity Ratio55.6%

How did 300401 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

13%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 08:07
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Garden Biopharmaceutical Co.,Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhe WangCitic Securities Co., Ltd.
Wei LiuHaitong International Research Limited
Song YangTianfeng Securities Brokerage Co., Ltd